Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 20 January 2027
- Last conf. stmt
- 6 January 2026
Convergence Pharmaceuticals Limited
- Incorporated
- 6 January 2015 (11 years)
- Previously known as
- Silver Newco Co Limited (until 24 April 2015)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Biogen Inc.
- Accounts type
- Small
- Region
- South East
- Address
- Building 5 Foundation ParkRoxborough WayMaidenheadSL6 3UD
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 14 July 2025
British
Born April 1982 (44)
Director · Appointed 1 July 2022
Australian
Born March 1975 (51)
Director · Appointed 21 February 2020
British
Born June 1966 (60)
Officer history (7 former)
14 July 2025
14 July 2025
1 June 2023
1 June 2023
1 July 2022
30 April 2022
24 April 2020
21 April 2020
21 February 2020
21 February 2020
31 January 2020
12 April 2018
Resigned Tate, Simon Nicholas, Mr. as Director
12 April 2018
2 June 2015
Appointed Tate, Simon Nicholas, Mr. as Director
30 March 2015
6 January 2015
6 January 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Biogen Inc.
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 33-0112644
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 16 September 2026 | Accounts for a small company | 31 December 2025 | ||
| 10 September 2026 | Director's details changed |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →